Immunohistochemical Study on Distribution of NF-κB and p53 in Gerbil Hippocampus after Transient Cerebral Ischemia: Effect of Pitavastatin (original) (raw)
Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y (1997) Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung 47:904–909 PubMedCAS Google Scholar
Araki T, Kato H, Kogure K (1989) Selective neuronal vulnerability following transient cerebral ischemia in gerbils: Distribution and time course. Acta Neurol Scand 80:548–533 ArticlePubMedCAS Google Scholar
Banasiak KJ, Haddad GG (1998) Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res 797:295–304 ArticlePubMedCAS Google Scholar
Bhakar AL, Tannis LL, Zeindler C, Russo MP, Jobin C, Park D, MacPherson S, Barker PA (2002) Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Nuerosci 22:8466–8475 CAS Google Scholar
Buttini M, Sauter A, Boddeke HW (1994) Induction of interleukin-1β mRNA after focal cerebral ischemia in the rat. Mol Brain Res 23:126–134 ArticlePubMedCAS Google Scholar
Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA (1996) Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272:542–545 ArticlePubMedCAS Google Scholar
Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14 ArticlePubMedCAS Google Scholar
Crumrine RC, Thomas AL, Morgan PF (1994) Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14:887–891 PubMedCAS Google Scholar
Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP, Krieglstein J (2003) Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 23:8586–8595 PubMedCAS Google Scholar
Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880–8885 ArticlePubMedCAS Google Scholar
Feuerstein GZ, Liu T, Barone FC (1994) Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 6:341–360 PubMedCAS Google Scholar
Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi FM, Pfeiffer J, Kaltschmidt C, Israel A, Memet S (2003) Forebrain-specific neuronal inhibition of nuclear factor-κB activity leads to loss of neuroprotection. J Neurosci 23:9403–9408 PubMedCAS Google Scholar
Fujimoto H, Kojima J, Yamada Y, Kanda H, Kimata H (1999) Studies on the metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase (4): interspecies variation in laboratory animals and humans. Xenobiot Metab Dispos 14:79–91 Google Scholar
Gabriel C, Justicia C, Camins A, Planas AM (1999) Activation of nuclear factor-kappa B in the rat brain after transient focal ischemia. Mol Brain Res 65:61–69 ArticlePubMedCAS Google Scholar
Guo Q, Robinson N, Mattson MP (1998) Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis. J Biol Chem 273:12341–12351 ArticlePubMedCAS Google Scholar
Halterman MW, Miller CC, Federoff HJ (1999) Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 19:6818–6824 PubMedCAS Google Scholar
Hayashi T, Hamakawa K, Nagotani S, Jin G, Li F, Deguchi K, Sehera Y, Zhang H, Nagano I, Shoji M, Abe K (2005) HMG CoA reductase inhibitors reduce ischemic brain injury of rats through decreasing oxidative stress on neurons. Brain Res 1037:52–58 ArticlePubMedCAS Google Scholar
Himeda T, Hayakawa N, Tounai H, Sakuma M, Kato H, Araki T (2005) Alterations of interneurons of the gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin. Neuropsychopharmacology 30:2014–2025 ArticlePubMedCAS Google Scholar
Kajinami K, Koizumi J, Ueda K, Miyamoto S, Takegoshi T, Mabuchi H (2000) Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Am J Cardiol 85:178–183 ArticlePubMedCAS Google Scholar
Kato H, Kogure K, Araki T, Itoyama Y (1995) Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res 694:85–93 ArticlePubMedCAS Google Scholar
Kirino T (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57–69 ArticlePubMedCAS Google Scholar
Kojima J, Fujino H, Abe H, Yoshimura M, Kanda H, Kimata H (1999) Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile. Biol Pharm Bull 22:142–150 PubMedCAS Google Scholar
Kumagai R, Oki C, Muramatsu Y, Kurosaki R, Kato H, Araki T (2004) Pitavastatin, a 3-hydroxy-3-methylglutaryl-conenzyme A (HMG-CoA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbils. J Neural Transm 111:1103–1120 ArticlePubMedCAS Google Scholar
Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T (2002) Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res 24:655–662 ArticlePubMedCAS Google Scholar
Makarov SS (2000) NF-κB activity as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6:441–448 ArticlePubMedCAS Google Scholar
Mattson MP, Camandola S (2001) NF-κB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107:247–254 ArticlePubMedCAS Google Scholar
McGahan L, Hakim AM, Robertson GS (1998) Hippocampal Myc and p53 expression following transient global ischemia. Mol Brain Res 56:133–145 ArticlePubMedCAS Google Scholar
Morris EJ, Keramaris E, Rideout HJ, Slack RS, Dyson NJ, Stefanis L, Park DS (2001) Cyclin-dependent kinases and p53 pathways are activated independently and mediate Bax activation in neurons after DNA damage. J Neurosci 21:5017–5026 PubMedCAS Google Scholar
Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA (1996) Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337–1345 PubMedCAS Google Scholar
Morrison RS, Kinoshita Y (2000) The role of p53 in neuronal cell death. Cell Death Differ 7:868–879 ArticlePubMedCAS Google Scholar
Moynagh PN, Williams DC, O’Neill LA (1993) Interleukin-1 activates transcription factor NF kappa B in glial cells. Biochem J 294:343–347 PubMedCAS Google Scholar
Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T (2003) Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 42:307–313 ArticlePubMed Google Scholar
Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001–1011 PubMedCAS Google Scholar
Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J (2004) Nuclear factor-kB contributes to infarction after permanent focal ischemia. Stroke 35:987–991 ArticlePubMed Google Scholar
Portera-Gailliau C, Henderson JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775–3787 Google Scholar
Rosenson RS (2000) Biological basis for statin therapy in stroke prevention. Curr Opin Neurol 13:57–62 ArticlePubMedCAS Google Scholar
Schmidt-Kastner R, Freund TF (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40:599–636 ArticlePubMedCAS Google Scholar
Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-kB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554–559 ArticlePubMedCAS Google Scholar
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-κB transcription factor and HIV-1. EMBO J 10:2247–2258 PubMedCAS Google Scholar
Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr (1995) Evidence for apoptotic cell death in Alzheimer’s disease. Exp Neurol 133:225–230 ArticlePubMedCAS Google Scholar
Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, Clemens J (2000) Transcription factor nuclear factor-κB is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 20:592–603 ArticlePubMedCAS Google Scholar
Urabe T, Yamasaki Y, Hattori N, Yoshikawa M, Uchida K, Mizuno Y (2000) Accumulation of 4-hydroxynonenal-modified proteins in hippocampal CA1 pyramidal neurons precedes delayed neuronal damage in the gerbil brain. Neuroscience 100:241–250 ArticlePubMedCAS Google Scholar
Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS (1996) Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753–6765 PubMedCAS Google Scholar
Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS (1998) Bax involvement in p53-mediated neuronal cell death. J Neurosci 18:1363–1373 PubMedCAS Google Scholar
Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17:7415–7424 PubMedCAS Google Scholar
Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP (1999) Lack of the p50 subunit of nuclear factor-kB increase the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci 19:8856–8865 PubMedCAS Google Scholar